Impact of outpatient non-myeloablative haematopoietic stem cell transplantation in quality of life vs. conventional therapy

References

• Bieri, S., Roosnek, E., Helg, C., Verholen, F., Robert, D., Chapuis, B., … Chalandon, Y. (2008). Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplantation, 42, 819–827. doi:10.1038/bmt.2008.253, bmt2008253 [pii]
   PubMed Web of Science ®Google Scholar
• Braamse, A. M., van Meijel, B., Visser, O., van Oppen, P., Boenink, A. D., Eeltink, C., … Dekker, J. (2010). Distress and quality of life after autologous stem cell transplantation: A randomized clinical trial to evaluate the outcome of a web-based stepped care intervention. BMC Cancer, 10, 361. doi:10.1186/1471-2407-10-361, 1471-2407-10-361 [pii]
   PubMed Web of Science ®Google Scholar
• Cantú-Rodríguez, O. G., Jaime-Pérez, J. C., Gutiérrez-Aguirre, C. H., Gonzalez-Llano, O., Mancias-Guerra, C., Tarín-Arzag, L., … Gómez-Almaguer, D. (2007). Outpatient allografting using non-myeloablative conditioning: The Mexican experience. Bone Marrow Transplantation, 40, 119–123. doi:10.1038/sj.bmt.1705700, 1705700 [pii]
   PubMed Web of Science ®Google Scholar
• Champlin, R. E., Schmitz, N., Horowitz, M. M., Chapuis, B., Chopra, R., Cornelissen, J. J., … Gratwohl, A. (2000). Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR histocompatibility and stem cell sources working committee and the European group for blood and marrow transplantation (EBMT). Blood, 95, 3702–3709.
   PubMed Web of Science ®Google Scholar
• Chao, N. J., Tierney, D. K., Bloom, J. R., Long, G. D., Barr, T. A., Stallbaum, B. A., … Blume, K. G. (1992). Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood, 80, 825–830.
   PubMed Web of Science ®Google Scholar
• Chiodi, S., Spinelli, S., Ravera, G., Petti, A. R., van Lint, M. T., Lamparelli, T., … Bacigalupo, A. (2000). Quality of life in 244 recipients of allogeneic bone marrow transplantation. British Journal of Haematology, 110, 614–619. bjh2053 [pii]
   PubMed Web of Science ®Google Scholar
• Danaher, E. H., Ferrans, C., Verlen, E., Ravandi, F., van Besien, K., Gelms, J., … Dieterle, N. (2006). Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncology Nursing Forum, 33, 614–624. doi:10.1188/06.ONF.614-624
   PubMed Web of Science ®Google Scholar
• Gomez-Almaguer, D., Ruiz-Arguelles, G. J., Ruiz-Arguelles, A., Gonzalez-Llano, O., Cantu, O. E., & Hernandez, N. E. (2000). Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: Report of four cases. Bone Marrow Transplantation, 25, 131–133. doi:10.1038/sj.bmt.1702100
   PubMed Web of Science ®Google Scholar
• Grant, M., Cooke, L., Williams, A. C., Bhatia, S., Popplewell, L., Uman, G., … Forman, S. (2012). Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: A comparison of sociodemographic, disease, and treatment characteristics. Supportive Care in Cancer, 20, 2697–2704. doi:10.1007/s00520-012-1389-8
   PubMed Web of Science ®Google Scholar
• Hacker, E. D. (2003). Quantitative measurement of quality of life in adult patients undergoing bone marrow transplant or peripheral blood stem cell transplant: A decade in review. Oncology Nursing Forum, 30, 613–629. doi:10.1188/03.ONF.613-629
   PubMedGoogle Scholar
• Jung, Y., Bauer, G., & Nolta, J. A. (2012). Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: Progress toward safe clinical products. Stem Cells, 30, 42–47. doi:10.1002/stem.727
   PubMed Web of Science ®Google Scholar
• Lizan Tudela, L., & Reig Ferrer, A. (1999). Cross cultural adaptation of a health related quality of life measurement: The Spanish version of the COOP/WONCA cartoons. Aten Primaria, 24, 75–82.
   PubMedGoogle Scholar
• McQuellon, R. P., Russell, G. B., Rambo, T. D., Craven, B. L., Radford, J., Perry, J. J., … Hurd, D. D. (1998). Quality of life and psychological distress of bone marrow transplant recipients: The ‘time trajectory’ to recovery over the first year. Bone Marrow Transplantation, 21, 477–486. doi:10.1038/sj.bmt.1701115
   PubMed Web of Science ®Google Scholar
• Mosher, C. E., DuHamel, K. N., Rini, C., Corner, G., Lam, J., & Redd, W. H. (2011). Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Supportive Care in Cancer, 19, 1357–1365. doi:10.1007/s00520-010-0958-y
   PubMed Web of Science ®Google Scholar
• Niederbacher, S., Them, C., Pinna, A., Vittadello, F., & Mantovan, F. (2012). Patients’ quality of life after allogeneic haematopoietic stem cell transplantation: Mixed-methods study. European Journal of Cancer Care, 21, 548–559. doi:10.1111/j.1365-2354.2012.01345.x
   PubMed Web of Science ®Google Scholar
• Pallua, S., Giesinger, J., Oberguggenberger, A., Kemmler, G., Nachbaur, D., Clausen, J., … Holzner, B. (2010). Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplantation, 45, 1534–1539. doi:10.1038/bmt.2010.5, bmt20105 [pii]
   PubMed Web of Science ®Google Scholar
• Pidala, J., Anasetti, C., & Jim, H. (2009). Quality of life after allogeneic hematopoietic cell transplantation. Blood, 114, 7–19. doi:10.1182/blood-2008-10-182592
   PubMed Web of Science ®Google Scholar
• Resnick, I. B., Shapira, M. Y., & Slavin, S. (2005). Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Transplant Immunology, 14, 207–219. doi:10.1016/j.trim.2005.03.009
   PubMed Web of Science ®Google Scholar
• Ruiz-Arguelles, G. J., Gomez-Almaguer, D., Ruiz-Arguelles, A., Gonzalez-Llano, O., Cantu, O. G., & Jaime-Perez, J. C. (2001). Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens. American Journal of Hematology, 66, 241–244. doi:10.1002/ajh.1051
   PubMed Web of Science ®Google Scholar
• Shigematsu, A., Yamamoto, S., Sugita, J., Kondo, T., Onozawa, M., Kahata, K., … Imamura, M. (2010). Increased risk of bacterial infection after engraftment in patients treated with allogeneic bone marrow transplantation following reduced-intensity conditioning regimen. Transplant Infectious Disease, 12, 412–420. doi:10.1111/j.1399-3062.2010.00560.x, TID560 [pii]
   PubMed Web of Science ®Google Scholar
• Slovacek, L., Slovackova, B., & Jebavy, L. (2005). Global quality of life in patients who have undergone the hematopoietic stem cell transplantation: Finding from transversal and retrospective study. Experimental Oncology, 27, 238–242. doi:23/447 [pii]
   PubMed Web of Science ®Google Scholar
• Syrjala, K. L., Langer, S. L., Abrams, J. R., Storer, B., Sanders, J. E., Flowers, M. E., … Martin, P. J. (2004). Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA, 291, 2335–2343. doi:10.1001/jama.291.19.2335
   PubMed Web of Science ®Google Scholar
• Tichelli, A., Rovo, A., Passweg, J., Schwarze, C. P., Van Lint, M. T., Arat, M., & Socie, G. (2009). Late complications after hematopoietic stem cell transplantation. Expert Review of Hematology, 2, 583–601. doi:10.1586/ehm.09.48
   PubMed Web of Science ®Google Scholar
• World Health Organization Quality of Life Assessment. (1995). The world health organization quality of life assessment (WHOQOL): Position paper from the world health organization. Social Science & Medicine, 41, 1403–1409. doi:10.1016/0277-9536(95)00112-K
   PubMed Web of Science ®Google Scholar